70.00 (-%)
As of Dec 06, 2024
Source:
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological, pulmonary and cardiovascular disorders with high unmet medical need.
Country | United States |
Headquarters | lexington, massachusetts |
Phone Number | 617-314-6297 |
Industry | manufacturing |
CEO | Jasbir Seehra, Ph.D. |
Website | www.clinicaltrials.gov |